/wp-content/uploads/page-bg-internal.jpg
/wp-content/uploads/page-banner-pillars-UVA.jpg
News & Media

APLU Letter to the FDA on Changes to the International Regulation of Ketamine

APLU submitted a letter to the Food and Drug Administration (FDA) expressing concern with potential changes to the international regulation of ketamine, as they would result in increased difficulty for biomedical researchers to use the drug for legitimate and appropriate treatments.

Subscribe to RSS

Browse By Date

Mon Tue Wed Thu Fri Sat Sun
 12345
6789101112
13141516171819
20212223242526
2728